Articles On Medadvisor (ASX:MDR)

Title Source Codes Date
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Stockhead MDR 15 hours ago
ASX Health Stocks: Health app MedAdvisor maintains guidance, but share price slips 5pc

The ASX 200 Health Index (XHJ) is down by 0.70% at the time of writing, compared to the broader index which is down by 0.55%. Health tech MedAdvisor (ASX:MDR) held its AGM this morning, in which it outlined the company’s strategic prioritie...

Stockhead MDR 1 week ago
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Stockhead MDR 2 weeks ago
Reporting Season Round Up: Leading the charge was Playside – the ASX’s local games developer

Today’s top stock was Playside Studios (ASX:PLY), the only ASX listed e-sports developer that’s based in Australia.   Playside Studios (ASX:PLY) Playside is also the newest listed ASX company in this space, debuting last December at 20 cent...

Stockhead MDR 1 month ago
10 at 10: These ASX stocks are the most in vogue with investor tastes this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead MDR 3 months ago
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Stockhead MDR 3 months ago
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Stockhead MDR 3 months ago
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Stockhead MDR 4 months ago
Utilities, tech stocks drag ASX; BHP, Rio Tinto hit fresh record high

Summary The ASX 200 dropped by 10.50 points or 0.14% to 7,406.90 by lunch. Barring materials, all sectors were trading in red, while utilities and tech declined the most. Origin Energy was the top laggard on ASX, falling nearly 9%. N...

Kalkine Media MDR 4 months ago
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Stockhead MDR 4 months ago
Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Stockhead MDR 5 months ago
Why the MedAdvisor (ASX:MDR) share price jumped 12% today

The MedAdvisor Ltd (ASX: MDR) share price is on the rise today after the company announced a US business update. The medication management platform provider’s shares are currently up 12% to 32.5 cents. Why did the MedAdvisor share price...

Motley Fool MDR 5 months ago
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Stockhead MDR 5 months ago
Your 90-second guide to the day in tech

It’s Thursday and who knew buying an Xbox was a bargain? Here’s the news from around the world.   Trump’s Facebook comeback? While Facebook’s independent oversight board may have decided to back the company’s January suspension of former Pr...

Startup Daily MDR 7 months ago
Last Orders: ASX 200 defies global equities rout to finish on a high note

The ASX 200 managed to hold on to its lunchtime gains today, finishing the day higher by 0.43 per cent. Health care and Information Tech were the best and worst performing sectors respectively. Geospatial tech company Nearmap (ASX:NEA) rose...

Stockhead MDR 7 months ago
Last Orders: Tech stocks lost nearly 2 per cent; but the rest of the ASX in the green

On a day the ASX finished nearly 0.5 per cent up, tech stood alone in the red losing more than 2 per cent. The ASX 200 closed 0.56 per cent up at 7,068 points and the ASX Emerging Companies Index rose 0.41 per cent closing at 2,111 points....

Stockhead MDR 7 months ago
MoneyTalks: Gleneagle gives us 3 good value stock picks for rampant times

Stockhead taps an extensive list of experts in Money Talks, our regular drill down into the stocks investors are looking at right now. Today, we hear from Justin Rosenberg, executive director of corporate finance at Gleneagle Securities.  ...

Stockhead MDR 8 months ago
The MedAdvisor (ASX:MDR) share price is lifting today. Here’s why

The MedAdvisor Ltd (ASX: MDR) share price is soaring today after the company announced an extension of a health program deal. In early afternoon trade, the medication management platform provider’s shares are swapping hands for 33.5 cents,...

Motley Fool MDR 8 months ago
Why Brickworks, McPherson’s, MedAdvisor, & Premier Investments are storming higher

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on form and pushing higher again. At the time of writing, the benchmark index is up 0.3% to 6,799.7 points. Four ASX shares that are climbing more than most today are listed...

Motley Fool MDR 8 months ago
Market highlights and 5 ASX small caps to watch on Thursday

Global stock markets dipped Stock markets dipped globally on fears over a potential third lockdown in Europe. Wall Street has seesawed throughout the week, as European shares hit a two-week low. Dow Jones was down 0.01%, S&P 500 fell by...

Stockhead MDR 8 months ago
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Stockhead MDR 8 months ago
Your 90-second guide to the day in tech

G’day gang, it’s Thursday already. Here’s your local and global tech news. Don’t forget to tune in for the Startup Daily show on Ausbiz.com.au  every weekday, 2-2.45pm. Watch online, download the ausbiz app or via 7Plus. Square buys BTC Ja...

Startup Daily MDR 9 months ago
MedAdvisor (ASX:MDR) provides business update

Summary MedAdvisor has experienced significant growth in the US after an acquisition, which was completed in November.  It is also entering new markets to drive the expansion of its platform.  MedAdvisor (ASX:MDR) shares closed nea...

Kalkine Media MDR 10 months ago
Three healthcare stocks with stellar returns in 2020

Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic.  However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P...

Kalkine Media MDR 11 months ago
The First Connection

Future prospects of the health booking platform – 1st Group – with some new opportunities on the horizon By Tim Boreham How a founder’s ASX-listed healthcare platform saved his own life Health platform founder Klaus Bartosch offers an unusu...

FNArena MDR 11 months ago
Why the MedAdvisor (ASX:MDR) share price is pushing higher today

The MedAdvisor Ltd (ASX: MDR) share price has been a positive performer on Monday morning. At the time of writing, the medication management platform provider’s shares are up 2.5% to 40 cents. Why is the MedAdvisor share price pushing high...

Motley Fool MDR 1 year ago
MedAdvisor (ASX:MDR) share price shoots up 8% today. Here’s why.

The MedAdvisor Ltd (ASX: MDR) share price is up 8.22% to 40 cents after the medtech company released second-half results for its newly acquired Adheris subsidiary. The results show that Adheris is performing stronger than expected.  Wha...

Motley Fool MDR 1 year ago
2 ASX small cap healthcare shares growing quickly

Earlier this week I looked at a couple of healthcare shares that have been tipped as potential market-beaters. Today, I thought I would take a look at the healthcare sector again, but this time at the small end of town. Two small cap healt...

Motley Fool MDR 1 year ago
Why Afterpay, Goodman, MedAdvisor, & PointsBet shares are dropping lower

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is pushing higher. At the time of writing, the benchmark index is up 0.2% to 6,498.3 points. Four shares that have failed to follow the marke...

Motley Fool MDR 1 year ago
Why the MedAdvisor (ASX:MDR) share price jumped 9% on Friday

The MedAdvisor Ltd (ASX: MDR) share price was a strong performer on Friday. The medication management platform provider’s shares were up as much as 9% to 42.5 cents at one stage. The MedAdvisor share price ultimately ended the day 6.5% hig...

Motley Fool MDR 1 year ago
MedAdvisor backflips and offers discount on share offer

Medical software group MedAdvisor (ASX: MDR) has come to the diagnosis that a discount may work better for its recently launched capital raise to acquire US-based Adheris Health. Earlier this week the Melbourne-based group launched a $45...

BusinessNewsAus MDR 1 year ago
MedAdvisor Ltd (ASX:MDR) share price halted ahead of transformational $49 million acquisition

The MedAdvisor Ltd (ASX: MDR) share price will be one to watch later this week when it returns from its trading halt. Why is Medadvistor in a trading halt? This afternoon the medication management platform provider requested a trading halt...

Motley Fool MDR 1 year ago
MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

Medical software group MedAdvisor (ASX: MDR) is prepared to massively dilute current shareholdings to secure the funds for a $49 million acquisition of Adheris LLC. The Melbourne-based company has entered into a binding agreement to acqui...

BusinessNewsAus MDR 1 year ago
Health-tech startup MedAdvisor is looking to raise $45 million as it buys a US medication venture for $49 million

Shares in ASX-listed MedAdvisor have been placed in a trading halt today with the health-tech venture announcing plans to acquire US-based medication adherence company Adheris for US$34.5 million (AU$49m), while also raising AU$45 million t...

Startup Daily MDR 1 year ago
3 small cap ASX healthcare shares to watch closely in the 2020s

If you’re interested in gaining exposure to the small cap side of the market, I think it could be worth looking for options in the healthcare sector. In this sector there are a number of companies that are benefiting from favourable tailwi...

Motley Fool MDR 1 year ago
Add these 3 ASX medical technology companies to your watch list

Medical technology is a broad field covering areas like biotechnology, pharmaceuticals, and information technology. Advancements in medical technology improve the way doctors diagnose and treat patients, leading to better health outcomes....

Motley Fool MDR 1 year ago
The healthcare winners and losers after COVID-19, and what comes next

Fortunes were to be made in ASX health stocks during March and April as investors looked for salvation from the COVID-19 pandemic fears rocking markets. However, once the two biggest health stocks Resmed (ASX:RMD) and CSL (ASX:CSL) are take...

Stockhead MDR 1 year ago
3 exciting small cap ASX healthcare shares to watch

The Australian share market is home to a number of world class healthcare companies such as Ramsay Health Care Limited (ASX: RHC) and Cochlear Limited (ASX: COH). While I believe both companies still have a lot of growth left in them, the...

Motley Fool MDR 1 year ago
3 exciting small cap ASX shares to watch very closely

Right now, I believe that are a number of small cap ASX shares that have the potential to grow into much larger entities in the future. Three small cap shares which I feel would be worth keeping a close eye on are listed below. Here’s why...

Motley Fool MDR 1 year ago
Trading Places: Regal has sunk another $3.2m into this small cap telco

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Stockhead MDR 1 year ago
3 exciting small cap ASX healthcare shares to watch

Due to new technologies and favourable industry tailwinds, I think there are a number of small cap ASX healthcare shares which have the potential to grow materially over the next 10 years. Three small cap healthcare shares to add to your w...

Motley Fool MDR 1 year ago
ScoPo’s health powerplays: Ramp ups and turnaround favs

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Cochlear’s...

Stockhead MDR 1 year ago
3 exciting ASX healthcare shares to watch in the 2020s

One area of the market that I think is a good place to look for buy and hold options is the small end of the healthcare sector. I think here you’ll find a number of companies that have the potential to grow significantly in the future than...

Motley Fool MDR 1 year ago
3 small cap ASX healthcare shares with enormous potential

When it comes to investing in world class healthcare companies, the Australian share market is home to a number of them such as Cochlear Limited (ASX: COH) and Ramsay Health Care Limited (ASX: RHC). While these blue chip shares certainly h...

Motley Fool MDR 1 year ago
MedAdvsor helps to address isolation and quarantining issues during COVID-19 pandemic

Shares in MedAdvisor Limited (ASX:MDR), traded up to 10% higher on Monday after the company announced that its telehealth and on-demand home delivery features are now live. The company is a prominent technology partner used by about 60% of...

FinFeed MDR 1 year ago
Investors can’t get enough of telehealth as global funding surges in Q3

Global funding for telehealth companies surged in the March quarter as investors jumped on what will clearly be a trend for 2020. A total of $US788m ($1.3bn) was invested into this sector making it the top funded digital health segment in t...

Stockhead MDR 1 year ago
3 startups show how they maintain team morale when working from home

      Working from home was once an office perk. Now, after a month of everyone being forced to do it in a bid to flatten the curve on coronavirus, plenty of people are realising how much they miss the routine of getting up and heading to...

Startup Daily MDR 1 year ago
ASX Microcap Madness March 2020

Following the excellent analysis of how volatile March 2020 was for the Dow Jones Industrial Average by Nick Maggiulli from Of Dollars & Data, I decided to take Nick’s methodology and see what it would reveal about the S&P/ASX Emerg...

Rask Media MDR 1 year ago
Directors Trades: This anti-snoring device maker needed capital to survive COVID-19; one director put in $3.7m

2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to keep going and one was sleep apnoea mouthguard maker Somnomed (ASX:SOM). In February, the company reported solid revenue and operating profi...

Stockhead MDR 1 year ago
MedAdvisor adds online GP telehealth consult service to protect patients during COVID-19

Digital medication management company MedAdvisor (ASX: MDR) will add a telehealth service to its online platform to help protect Australians from widespread impacts of the coronavirus pandemic. The company will extend the GP Link feature wi...

SmallCaps MDR 1 year ago